Rubicon Organics Announces the Results of the Annual General and Special Meeting and Grants DSUs

Core Viewpoint - Rubicon Organics Inc. held its Annual General and Special Meeting, where shareholders approved several key matters, including the election of directors and the adoption of a new Omnibus Equity Incentive Plan [1][2][3]. Shareholder Meeting Results - A total of 40,039,174 shares were represented at the Meeting, accounting for approximately 71% of the total issued and outstanding common shares [2]. - Shareholders approved the following matters: - Setting the number of directors at eight [3]. - Electing eight directors for the upcoming year [3]. - Appointing PricewaterhouseCoopers LLP as auditors for the next year [3]. - Approving the new Omnibus Equity Incentive Plan [3]. Changes to Board of Directors - David Donnan did not seek re-election after serving since 2018, during which he held various roles including Chair of the Audit Committee [4]. - The CEO expressed gratitude for Donnan's contributions to the company [5]. Omnibus Equity Incentive Plan - The Omnibus Equity Incentive Plan was approved on May 31, 2024, and allows for the issuance of various equity awards [6]. - The plan has a maximum issuance limit of 4,846,192 common shares and replaces the legacy equity incentive plan [7]. - An aggregate of 1,316,233 Deferred Share Units (DSUs) has been granted to independent directors as compensation for their services [8]. Company Overview - Rubicon Organics Inc. is a leading producer of premium organic cannabis products, focusing on profitability through its product innovation and brand management [10]. - The company operates a state-of-the-art facility in Delta, BC, ensuring quality through its vertically integrated supply chain [11].